Long-Term Effects of Metabolic Stress on Human Malignant Melanoma Cell Line

被引:0
|
作者
Nakhjavani, Maryam [1 ]
Shirazi, Farshad H. [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Shahid Beheshti Sch Pharm, Dept Tox Pharmacol, Tehran, Iran
[2] Shahid Beheshti Med Univ, Pharmaceut Sci Res Ctr, Tehran, Iran
关键词
A375; Neoplasm; Serum; Starvation; Metabolic Stress; HUMAN LUNG; CANCER; RESISTANCE; HETEROGENEITY; CYTOTOXICITY; DERIVATIVES; EXPOSURE; BIOLOGY; GROWTH; LEVEL;
D O I
10.5530/ijper.52.4.70
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Introduction: Tumour is a heterogeneous tissue consisting of cells with different levels of metabolic activity. Often the outer layer cells of a tumour have more optimal conditions to grow/proliferate compared to the inner cells. Objective: The aim of the current study was to study the reactions of malignant melanoma A375 cells in exposure to different levels of metabolic stress and their ability to returning to life upon re-exposure to optimum nutritional conditions. Methods: A375 cells, at early plateau phase, were exposed to media containing 10% (control), 0.5, 0.25 and 0% serum for 1 to 6 days. At 24 h intervals, the cells were tested for morphology, cell cycle distribution, cell size changes, cell count, mitochondrial function and protein content. Also, after each day of starvation, the cells were re-exposed to optimum media (10% serum) and tested again. Results: The results showed that the cells made foci structures at long-term starvation. They primarily accumulated in G1-phase and at long-term starvation, most of them entered the apoptotic state. However, before death, cell count did not decrease, even though the mitochondrial function and protein content were less than the control cells. Releasing the cells in optimum conditions could trigger cells' proliferation ability, mitochondrial function and protein content. Conclusion: The results suggest that this model of malignant melanoma has a resistant feature against sub-optimal nutritional and metabolic status and the cells can return to life with even stronger internal engines, as evidenced by higher levels of mitochondrial function and protein content.
引用
收藏
页码:602 / 609
页数:8
相关论文
共 50 条
  • [31] Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma
    Gkalpakiotis, Spyridon
    Arenberger, Petr
    Fridman, Marketa
    Arenbergerova, Monika
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [32] Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma
    Groffik, A.
    Mueller-Brenne, T.
    Rudolph, B.
    Rietz, S.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [33] Pulmonary metastasectomy for malignant melanoma: prognostic factors for long-term survival
    Younes, Riad
    Abrao, Fernando C.
    Gross, Jefferson
    MELANOMA RESEARCH, 2013, 23 (04) : 307 - 311
  • [34] Multiple brain metastases from malignant melanoma with long-term survival
    Hamid, NA
    Chandra, A
    Meyer, CHA
    BRITISH JOURNAL OF NEUROSURGERY, 2004, 18 (05) : 552 - 555
  • [35] INCREASE OF THE MALIGNANT POTENTIAL OF HUMAN LINE HBL-100 WITH LONG-TERM PASSAGE INVITRO
    GIOVANELLA, BC
    GAFFNEY, EV
    YIM, SO
    STEHLIN, JS
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1980, 16 (03): : 211 - 211
  • [36] CYTO-TOXIC EFFECT OF AN AUTOLOGOUS LONG-TERM T-CELL LINE (LTTC) IN A PATIENT WITH MALIGNANT-MELANOMA - ADOPTIVE AUTOIMMUNOTHERAPY
    SLANKARDCHAHINIAN, M
    HOLLAND, JF
    GORDON, RE
    BECKER, J
    OHNUMA, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 374 - 374
  • [37] BIOLOGICAL AND BIOCHEMICAL FEATURES AND FLOW-CYTOMETRY OF A HUMAN-MELANOMA CELL-LINE DURING LONG-TERM CULTIVATION
    BLASKO, M
    SIRACKY, J
    KULIFFAY, P
    BOROVANSKY, J
    SIRACKA, E
    KYSELA, B
    CHALUPA, I
    BIZIK, J
    PIGMENT CELL RESEARCH, 1988, 1 (04): : 291 - 291
  • [38] THE LONG-TERM EFFECTS OF THERAPY FOR MALIGNANT DISEASE IN CHILDHOOD
    MORRISJONES, PH
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1980, 14 (03): : 178 - 180
  • [39] EFFECTS OF TREATMENT ON LONG-TERM SURVIVORS WITH MALIGNANT ASTROCYTOMAS
    IMPERATO, JP
    PALEOLOGOS, NA
    VICK, NA
    ANNALS OF NEUROLOGY, 1990, 28 (06) : 818 - 822
  • [40] EFFECTS OF TREATMENT ON LONG-TERM SURVIVORS WITH MALIGNANT ASTROCYTOMAS
    IMPERATO, JP
    VICK, NA
    ANNALS OF NEUROLOGY, 1989, 26 (01) : 180 - 181